INTRODUCTION
Tissue factor (TF) is an integral membrane glycoprotein which binds human zymogen factor VII and its active form serine protease factor VIla (1-3). The TF-VIIa complex serves as a potent initiator of the extrinsic and intrinsic coagulation pathways (4) . The observation that expression of TF, an immediate early gene, can be induced by growth factors and other cell ligands in various cell types raises the possibility that TF may also play a role in cell growth (5) . Immunohisto- chemical studies in normal human tissues using monoclonal antibodies found that TF expressed mainly at the interface of different organs and between the internal and external environments (6) . The expression pattern of TF was thus viewed as a hemostatic envelope serving to initiate the arrest of bleeding (7) . In malignancy, hypercoagulatory activity was often found in cancer patients (8, 9) . TF was viewed as a procoagulant in certain types of cancers (10) . Because of the ability of TF to initiate fibrin deposition and platelet aggregation, a potential role of TF in tumor metastasis was proposed (1, 12) . Immunohistochemical studies on solid tumors using polyclonal monospecific antibodies found Molecular Medicine, Volume 1, Number 2, January 1995 positive tumor cells from lung, squamous cell carcinoma of the head and neck, gastrointestinal mucosa, vaginal carcinoma, transitional cell carcinoma, pancreatic adenocarcinomas, and endometrial carcinoma. Some tumors such as breast and ovarian showed heterogeneous staining patterns. Renal cell carcinoma and prostate carcinoma, on the other hand, stained negative for TF (13) . Other studies on human breast tissues described both negative (14) and heterogeneous (15) (19) .
Differential Display
Removal of DNA from RNA and differential display were essentially the same as described previously (20, 21) with slight modification. TF was identified through a 5-way display in which RNA samples from 70N, 16E6E7-A5, 18-2-1, MDA-MB-435, and BT549 were used to screen for expression differences in normal primary, immortalized, and tumor derived cells. At the reamplification step, the arbitrary primer concentration was increased from the recommended 0.2 ,uM to 0.3 ,uM and the T12MN primer concentration was increased from 1 to 1.5 ,uM to obtain sufficient polymerase chain reaction (PCR) products in one round of reamplification.
Cloning and Sequencing of cDNA The procedure was described previously (20, 22 and an antisense primer 5 base pairs downstream of the stop codon TAA (5'-TGCKTAGATCCAA CAGTGC-3'). The underlined bases were changed from tissue factor sequence CTC to GCG in the upstream primer and AG and C to TC and A in the downstream primer to accommodate a NotI and XbaI site for each primer, respectively. The 936 base pair amplified fragment was used as a probe for Northern blots to confirm the expression pattern which had initially been identified by the 3' untranslated region.
Inmuunofluorescence Staining Cells were cultured in DFCI-1 in 8-well chamber slides (Nunc, Naperville, IL), rinsed twice with phosphate-buffered saline (PBS), and fixed in 100% acetone for 10 min at 40C. After PBS wash for 5 
RESULTS
In a 5-way differential display (Fig. 1) (24) . A 936 base pair fragment of TF coding region was obtained using RT-PCR from 76N RNA. This fragment was used for Northern blot analysis. Figure 2A shows the results of a Northern blot using the TF cDNA probe. Northern blot analysis using 76N RNA also showed that expression level of tissue factor mRNA remained high in growing and senescent normal mammary epithelial cells (Fig. 2B) . The fact that TF is expressed in normal, immortalized, and senescent cells as well as quiescent cells (data not shown) suggests that TF expression is independent of the proliferation status of the expressing mammary epithelial cells.
Immunofluorescence staining showed that TF was expressed in 70N, 81N, 1436N , 16E6E7-A2, and MDA-MB-231, but not in 2IMT, MDA-MB-435, and MCF-7 cells, the same pattern as that seen at the transcription level ( Fig. 2A) . Figure 3 shows the immunofluorescence staining of 81N. TF was found in the extending lamellipodia and the retracting uropod. The pattern appeared to be similar to stimulated MCF-7 cell lines in which cellular localization of TF was implicated in morphogenesis related to cell growth and differentiation (25) .
Immunohistochemical staining results showed that mammary epithelial cells in some normal ducts stained positive (brown) for TF (Fig. 4A) and those in other ducts stained negative (Fig. 4C) . As a control to Fig. 4A, Fig. 4B   FIG. 3 (Fig. 4E ).
DISCUSSION
Differential display (DD) has been shown to be a powerful tool to identify genes differentially expressed at the mRNA level (20, 21) . One of the advantages of DD is that it can be used conveniently to display and compare multiple samples simultaneously (22) . The original design of DD predicted the PCR products to be amplified between a T1 2MN and an arbitrary upstream primer. While many of the genes identified by DD meet the expectation of the original design, TF was amplified by T12 MA only. In the case of TF, the upstream primer is T12CA and the downstream primer is T12AA. T12CA matches human TF sequence 5'-TGAAAAAAAAAAGA-3' between position 1740 Figure 4D shows an example of myoepithelial immunostaining, defining the border of a residual duct. Immunostaining with TF clearly demarcates the break down of the basement structure as in Fig. 4E . Similar TF expression patterns were found in many areas of invasive cancer tissues. Similar expression patterns were also found in primary mammary carcinomas immunostained with maspin, a candidate tumor suppressor gene (26) , and with connexin 26, a gap junction protein (Tsukamoto and Sager, unpublished). These residual myoepithelial cells may still express normal functions, and therefore may play a local role in suppressing tumor growth.
The evidence that TF is expressed in some normal ducts and not in others suggests local environmental heterogeneity. TF is an immediate early gene (5) . Its expression in cell culture can be induced by growth factors such as platelet-derived growth factor, fibroblast growth factor, transforming growth factor 03 and epithelial growth factor (5, 27, 28) , and by steroid hormone such as estrogen (29) , and by cytokines such as interleukin-1 (IL-1), and tumor necrosis factor-a (TNF-a) (28) . Retinoic acid, IL-4, and IL-lO were found to counteract the induction of TF expression by other cytokines or endotoxin (30) (31) (32) . These observations were made mostly in endothelial cells, monocytes, and fibroblasts. A serum response element was characterized in TF promoter (33) . The evidence suggests that local cell proliferation or inflammatory activity may trigger the expression of the TF gene.
To test this hypothesis with mammary epithelial cells, we examined the effects of serum starvation, IL-1, and TNF-a on TF expression in cell culture. Northern blot analysis showed that human breast tumor cell lines, 2INT, MCF-7, and MDA-MB-435 did not respond to the treatments (data not shown). This result suggests that TF expression in these cell lines may be different from that in other cell types. It 
